A case of ceftriaxone-induced immune haemolytic anaemia in an ambulatory care setting

Background: Drug-induced immune haemolytic anaemia (DIIHA) is a rare adverse effect which varies between mild to fatal (Garratty, 2010). One of the most common class of drugs reported to cause severe DIIHA are the second and third generation cephalosporins (e.g. ceftriaxone) (Garratty, 2010; Hill et...

Descrición completa

Detalles Bibliográficos
Main Authors: Rakhee Mistry, Luke S.P. Moore, Nabeela Mughal, Andrew Godfrey, Stephen Hughes
Formato: Artigo
Idioma:English
Publicado: Elsevier 2024-01-01
Series:Clinical Infection in Practice
Subjects:
Acceso en liña:http://www.sciencedirect.com/science/article/pii/S2590170224000013